Catalyst Wire Dossier Catalyst Wire Dossier

Therapeutic HSV-2 vaccine

· Genocea Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Therapeutic HSV-2 vaccine, covering 2017-10-16 to 2017-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine [Phase 2]

See pricing